Advertisement
Advertisement
GDRX
GoodRx Holdings, Inc. Class A Common Stock
2.06
USDSponsored
+0.02
+0.74%
Mar 25, 15:46 UTC -4
Closed
Pre-Market
2.04
-0.02
-1.12%
GDRX Earnings Reports
Positive Surprise Ratio
GDRX beat 12 of 22 last estimates.
55%
Next Report
Date of Next Report
May 05, 2026
Estimate for Q1 26 (Revenue/ EPS)
$189.09M
/$0.07
Implied change from Q4 25 (Revenue/ EPS)
-2.93%
/-22.22%
Implied change from Q1 25 (Revenue/ EPS)
-6.84%
/-22.22%
GoodRx Holdings, Inc. Class A Common Stock earnings per share and revenue
On Feb 25, 2026, GDRX reported earnings of 0.09 USD per share (EPS) for Q4 25, missing the estimate of 0.09 USD, resulting in a -3.64% surprise. Revenue reached 194.78 million, compared to an expected 197.13 million, with a -1.19% difference. The market reacted with a -18.78% price change (close before vs. close after earnings).
Looking ahead to Q1 26, 12 analysts forecast an EPS of 0.07 USD, with revenue projected to reach 189.09 million USD, implying an decrease of -22.22% EPS, and decrease of -2.93% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
The Oncology Institute, Inc. Common Stock
Report Date
Mar 12, 2026 For Q4 25
Estimate
-$0.09
Actual
-$0.06
Surprise
+33.99%
The Beauty Health Company Class A Common Stock
Report Date
Mar 12, 2026 For Q4 25
Estimate
-$0.05
Actual
-$0.06
Surprise
-14.29%
Sera Prognostics, Inc. Class A Common Stock
Report Date
Mar 18, 2026 For Q4 25
Estimate
-$0.19
Actual
-$0.16
Surprise
+17.44%
DocGo Inc. Common Stock
Report Date
Mar 16, 2026 For Q4 25
Estimate
-$0.13
Actual
-$1.37
Surprise
-920.10%
HealthEquity, Inc
Report Date
Mar 17, 2026 For Q4 26
Estimate
$0.90
Actual
$0.95
Surprise
+4.51%
IceCure Medical Ltd. Ordinary Shares
Report Date
Mar 17, 2026 For Q4 25
Estimate
-$0.04
Actual
-$0.07
Surprise
-52.51%
Lifeward Ltd. Ordinary Shares
Report Date
Mar 18, 2026 For Q4 25
Estimate
-$1.10
Actual
-$3.60
Surprise
-226.80%
SeaStar Medical Holding Corporation Common Stock
Report Date
Mar 25, 2026 For Q4 25
Estimate
-$1.07
Actual
-$0.80
Surprise
+25.28%
Healthy Choice Wellness Corp.
Report Date
Mar 16, 2026 For Q4 25
Estimate
-$0.05
Actual
-$0.05
Surprise
+1.96%
Aclarion, Inc. Common Stock
Report Date
Mar 18, 2026 For Q4 25
Estimate
-$3.67
Actual
-$2.54
Surprise
+30.83%
FAQ
What were GoodRx Holdings, Inc. Class A Common Stock's earnings and revenue for the latest quarter Q4 2025?
For Q4 2025, GoodRx Holdings, Inc. Class A Common Stock reported EPS of $0.09, missing estimates by -3.64%, and revenue of $194.78M, -1.19% below expectations.
How did the market react to GoodRx Holdings, Inc. Class A Common Stock's Q4 2025 earnings?
The stock price moved down -18.78%, changed from $2.45 before the earnings release to $1.99 the day after.
When is GoodRx Holdings, Inc. Class A Common Stock expected to report next?
The next earning report is scheduled for May 05, 2026.
What are the forecasts for GoodRx Holdings, Inc. Class A Common Stock's next earnings report?
Based on 12
analysts, GoodRx Holdings, Inc. Class A Common Stock is expected to report EPS of $0.07 and revenue of $189.09M for Q1 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement